GCIA
GRCL

Gabelli & Co Investment Advisers’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34,300
Closed -$344K – 291
2023
Q4 		$344K Buy
+34,300
New +$344K 0.06% 138